250 related articles for article (PubMed ID: 30034942)
1. Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.
Marrufo AM; Mathew SO; Chaudhary P; Malaer JD; Vishwanatha JK; Mathew PA
Am J Cancer Res; 2018; 8(6):1050-1063. PubMed ID: 30034942
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
Mathew SO; Chaudhary P; Powers SB; Vishwanatha JK; Mathew PA
Oncotarget; 2016 Oct; 7(42):68650-68661. PubMed ID: 27626681
[TBL] [Abstract][Full Text] [Related]
3. Lectin-like transcript 1 as a natural killer cell-mediated immunotherapeutic target for triple negative breast cancer and prostate cancer.
Sun Y; Malaer JD; Mathew PA
J Cancer Metastasis Treat; 2019; 2019(5):. PubMed ID: 34322598
[TBL] [Abstract][Full Text] [Related]
4. Blocking PCNA interaction with NKp44 enhances primary natural killer cell-mediated lysis of triple-negative breast cancer cells.
Marrufo AM; Mathew SO; Chaudhary P; Malaer JD; Ahmed N; Vishwanatha JK; Mathew PA
Am J Cancer Res; 2023; 13(3):1082-1090. PubMed ID: 37034219
[TBL] [Abstract][Full Text] [Related]
5. Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer.
Buller CW; Mathew PA; Mathew SO
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630303
[TBL] [Abstract][Full Text] [Related]
6. Biological and Clinical Significance of Human NKRP1A/LLT1 Receptor/Ligand Interactions.
Bialoszewska A; Malejczyk J
Crit Rev Immunol; 2018; 38(6):479-489. PubMed ID: 31002602
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection impairs NK cell functions
Lenart M; Górecka M; Bochenek M; Barreto-Duran E; Szczepański A; Gałuszka-Bulaga A; Mazur-Panasiuk N; Węglarczyk K; Siwiec-Koźlik A; Korkosz M; Łabaj PP; Baj-Krzyworzeka M; Siedlar M; Pyrc K
Front Immunol; 2023; 14():1123155. PubMed ID: 37287972
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).
Kamishikiryo J; Fukuhara H; Okabe Y; Kuroki K; Maenaka K
J Biol Chem; 2011 Jul; 286(27):23823-30. PubMed ID: 21572041
[TBL] [Abstract][Full Text] [Related]
9. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.
Germain C; Meier A; Jensen T; Knapnougel P; Poupon G; Lazzari A; Neisig A; Håkansson K; Dong T; Wagtmann N; Galsgaard ED; Spee P; Braud VM
J Biol Chem; 2011 Nov; 286(44):37964-37975. PubMed ID: 21930700
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A.
Kita S; Matsubara H; Kasai Y; Tamaoki T; Okabe Y; Fukuhara H; Kamishikiryo J; Krayukhina E; Uchiyama S; Ose T; Kuroki K; Maenaka K
Eur J Immunol; 2015 Jun; 45(6):1605-13. PubMed ID: 25826155
[TBL] [Abstract][Full Text] [Related]
11. Lectin-Like Transcript 1 (LLT1) Checkpoint: A Novel Independent Prognostic Factor in HPV-Negative Oropharyngeal Squamous Cell Carcinoma.
Sanchez-Canteli M; Hermida-Prado F; Sordo-Bahamonde C; Montoro-Jiménez I; Pozo-Agundo E; Allonca E; Vallina-Álvarez A; Álvarez-Marcos C; Gonzalez S; García-Pedrero JM; Rodrigo JP
Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33255617
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals.
Tang M; Gao S; Zhang L; Liu B; Li J; Wang Z; Zhang W
Prostate; 2020 Jul; 80(10):742-752. PubMed ID: 32449811
[TBL] [Abstract][Full Text] [Related]
13. LLT1-CD161 Interaction in Cancer: Promises and Challenges.
Braud VM; Meghraoui-Kheddar A; Elaldi R; Petti L; Germain C; Anjuère F
Front Immunol; 2022; 13():847576. PubMed ID: 35185935
[TBL] [Abstract][Full Text] [Related]
14. A Role of NKR-P1A (CD161) and Lectin-like Transcript 1 in Natural Cytotoxicity against Human Articular Chondrocytes.
Białoszewska A; Olkowska-Truchanowicz J; Bocian K; Osiecka-Iwan A; Czop A; Kieda C; Malejczyk J
J Immunol; 2018 Jan; 200(2):715-724. PubMed ID: 29212911
[TBL] [Abstract][Full Text] [Related]
15. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.
Rosen DB; Cao W; Avery DT; Tangye SG; Liu YJ; Houchins JP; Lanier LL
J Immunol; 2008 May; 180(10):6508-17. PubMed ID: 18453569
[TBL] [Abstract][Full Text] [Related]
16. Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells.
Malaer JD; Mathew PA
Anticancer Res; 2020 Dec; 40(12):6613-6621. PubMed ID: 33288556
[TBL] [Abstract][Full Text] [Related]
17. LLT1-mediated activation of IFN-gamma production in human natural killer cells involves ERK signalling pathway.
Bambard ND; Mathew SO; Mathew PA
Scand J Immunol; 2010 Mar; 71(3):210-9. PubMed ID: 20415786
[TBL] [Abstract][Full Text] [Related]
18. Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
Sommaggio R; Cappuzzello E; Dalla Pietà A; Tosi A; Palmerini P; Carpanese D; Nicolè L; Rosato A
Oncoimmunology; 2020 Jun; 9(1):1777046. PubMed ID: 32923140
[TBL] [Abstract][Full Text] [Related]
19. Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.
Liu Y; Li M; Fang Z; Gao S; Cheng W; Duan Y; Wang X; Feng J; Yu T; Zhang J; Wang T; Hu A; Zhang H; Rong Z; Shakila SS; Shang Y; Kong F; Liu J; Li Y; Ma F
Cancer Immunol Immunother; 2024 May; 73(7):117. PubMed ID: 38713229
[TBL] [Abstract][Full Text] [Related]
20. Characterization of alternatively spliced transcript variants of CLEC2D gene.
Germain C; Bihl F; Zahn S; Poupon G; Dumaurier MJ; Rampanarivo HH; Padkjær SB; Spee P; Braud VM
J Biol Chem; 2010 Nov; 285(46):36207-15. PubMed ID: 20843815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
